Literature DB >> 12885573

Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease.

Judith Miklossy1, Kevin Taddei, Domizio Suva, Giuseppe Verdile, Justin Fonte, Christopher Fisher, Anastazija Gnjec, Joseph Ghika, Françoise Suard, Pankaj D Mehta, Catriona A McLean, Colin L Masters, William S Brooks, Ralph N Martins.   

Abstract

Mutations in the gene encoding presenilin 1 (PS-1) account for 50% of early-onset familial Alzheimer's disease (EOFAD) cases. In this study, we identified two missense mutations in the coding sequence of the presenilin (PS-1) gene in two EOFAD pedigrees. AD was confirmed in one pedigree by autopsy. Mutation analysis of PCR products amplified from genomic DNA templates showed two novel PS-1 mutations resulting in Gln222His and Tyr256Ser. The two novel mutations are located within predicted transmembrane domains five (TM-5) and six (TM-6), respectively, and are associated with very early ages of onset. The Tyr256Ser is associated with one of the youngest age of AD onset, 25 years, which is consistent with a drastic change in function of the altered PS-1 protein. A morphometric analysis of the cortical degenerative changes of the Tyr256Ser case, showed severe involvement of the primary motor cortex, which correlated well with the pyramidal changes, including tetraspasticity. Immunoblot analysis showed the Tyr256Ser case had the greatest expression of Abeta(1-40) and Abeta(1-42), which was confirmed by ELISA, compared to other PS-1 mutant FAD cases and age-matched controls and, thus, contributes to the severity of the disease pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885573     DOI: 10.1016/s0197-4580(02)00192-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  12 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation.

Authors:  M Anheim; D Hannequin; C Boulay; C Martin; D Campion; C Tranchant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

Review 3.  The genetics and neuropathology of Alzheimer's disease.

Authors:  Gerard D Schellenberg; Thomas J Montine
Journal:  Acta Neuropathol       Date:  2012-05-23       Impact factor: 17.088

4.  Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia.

Authors:  Pedro Braga-Neto; José Luiz Pedroso; Helena Alessi; Paulo Victor Sgobbi de Souza; Paulo Henrique Ferreira Bertolucci; Orlando Graziani Povoas Barsottini
Journal:  J Neurol       Date:  2013-03-13       Impact factor: 4.849

Review 5.  What is the dominant Abeta species in human brain tissue? A review.

Authors:  Gillian C Gregory; Glenda M Halliday
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 6.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

Review 7.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

8.  Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis.

Authors:  Julien Couthouis; Alya R Raphael; Roxana Daneshjou; Aaron D Gitler
Journal:  PLoS Genet       Date:  2014-10-09       Impact factor: 5.917

Review 9.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

Review 10.  Genetic heterogeneity in Alzheimer disease and implications for treatment strategies.

Authors:  John M Ringman; Alison Goate; Colin L Masters; Nigel J Cairns; Adrian Danek; Neill Graff-Radford; Bernardino Ghetti; John C Morris
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.